HEALTHCARE SERVICES GROUP INC (HCSG)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 700M 1.4B 2.1B FY08: 602.7M FY09: 692.7M FY10: 774M FY11: 889.1M FY12: 1.1B FY13: 1.1B FY14: 1.3B FY15: 1.4B FY16: 1.6B FY17: 1.9B FY18: 2B FY19: 1.8B FY20: 1.8B FY21: 1.6B FY22: 1.7B FY23: 1.7B FY24: 1.7B FY25: 1.8B FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 100M 200M 300M FY16: 223.2M FY17: 250.6M FY18: 234.4M FY19: 227.9M FY20: 268M FY21: 230.6M FY22: 193.3M FY23: 214.7M FY24: 228.1M FY25: 239.4M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Net Income Annual

0 35M 70M 105M FY08: 26.6M FY09: 30.3M FY10: 34.4M FY11: 38.2M FY12: 44.2M FY13: 47.1M FY14: 21.9M FY15: 58M FY16: 77.4M FY17: 88.2M FY18: 83.5M FY19: 64.6M FY20: 98.7M FY21: 48.5M FY22: 34.2M FY23: 38.4M FY24: 39.5M FY25: 59.1M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 700M 1.4B 2.1B FY16: 1.3B FY17: 1.6B FY18: 1.8B FY19: 1.6B FY20: 1.5B FY21: 1.4B FY22: 1.5B FY23: 1.5B FY24: 1.5B FY25: 1.6B FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-80M 0 80M 160M 240M FY08: 16.7M FY09: 38.3M FY10: 37.7M FY11: 32.9M FY12: 60.4M FY13: 32.2M FY14: 57.7M FY15: 63.4M FY16: 41.4M FY17: 7.6M FY18: 80M FY19: 93.6M FY20: 217.2M FY21: 37.1M FY22: -8.2M FY23: 43.5M FY24: 30.8M FY25: 145M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-80M 0 80M 160M 240M FY08: 15.1M FY09: 36.2M FY10: 33.6M FY11: 27.4M FY12: 56.9M FY13: 28.4M FY14: 51.9M FY15: 58.4M FY16: 36M FY17: 2.2M FY18: 75.1M FY19: 89.2M FY20: 212.9M FY21: 31.4M FY22: -13.4M FY23: 38.1M FY24: 24.5M FY25: 139.2M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 30M 60M 90M FY08: 66M FY09: 66.4M FY10: 67M FY11: 67.6M FY12: 68.5M FY13: 70M FY14: 71.3M FY15: 72.5M FY16: 73.5M FY17: 74.3M FY18: 74.6M FY19: 74.6M FY20: 74.8M FY21: 75M FY22: 74.4M FY23: 74.3M FY24: 74M FY25: 73M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.60 1.20 1.80 Q4 '10: 0.52 Q1 '11: 0.53 Q2 '11: 0.55 Q3 '11: 0.56 Q4 '11: 0.58 Q1 '12: 0.59 Q2 '12: 0.61 Q3 '12: 0.63 Q4 '12: 0.66 Q1 '13: 0.75 Q2 '13: 0.77 Q3 '13: 0.80 Q4 '13: 0.69 Q1 '14: 0.68 Q2 '14: 0.69 Q3 '14: 0.18 Q4 '14: 0.32 Q1 '15: 0.33 Q2 '15: 0.36 Q3 '15: 0.91 Q4 '15: 0.82 Q1 '16: 0.86 Q2 '16: 0.89 Q3 '16: 0.92 Q4 '16: 1.07 Q1 '17: 1.11 Q2 '17: 1.15 Q3 '17: 1.19 Q4 '17: 1.18 Q1 '18: 0.88 Q2 '18: 0.93 Q3 '18: 0.97 Q4 '18: 1.12 Q1 '19: 1.24 Q2 '19: 1.13 Q3 '19: 1.03 Q4 '19: 0.86 Q1 '20: 1.01 Q2 '20: 1.08 Q3 '20: 1.20 Q4 '20: 1.32 Q1 '21: 1.38 Q2 '21: 1.20 Q3 '21: 0.96 Q4 '21: 0.66 Q1 '22: 0.48 Q2 '22: 0.44 Q3 '22: 0.31 Q4 '22: 0.45 Q1 '23: 0.46 Q2 '23: 0.48 Q3 '23: 0.41 Q4 '23: 0.52 Q1 '24: 0.57 Q2 '24: 0.44 Q3 '24: 0.70 Q4 '24: 0.54 Q1 '25: 0.56 Q2 '25: 0.14 Q3 '25: 0.54 Q4 '25: 0.81 Q1 '26: 0.95 Q2 '26: 1.71 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.